openPR Logo
Press release

NGS-Based RNA-Sequencing Market Recent Developments Study Analysis By 2033

01-10-2024 01:57 PM CET | Health & Medicine

Press release from: Global Insight Services

NGS-Based RNA-Sequencing Market

NGS-Based RNA-Sequencing Market

Market Definition

NGS-based RNA Sequencing is used to protect against the intentional interference of electronic signals. This equipment can be used to protect against radio frequency interference (RFI), electromagnetic interference (EMI), or other types of signal interference.

Market Outlook

The global NGS-based RNA Sequencing Market was valued at USD 2.8 Billion in 2022 and it is anticipated to grow up to USD 21.3 Billion by 2032, at a CAGR of 22.5% during the forecast period.

NGS-based RNA Sequencing is used to protect against the intentional interference of electronic signals. This equipment can be used to protect against radio frequency interference (RFI), electromagnetic interference (EMI), or other types of signal interference. There are a variety of anti-jamming technologies that can be used, depending on the type of interference that is being protected against. For example, RFI jamming can be countered with frequency-hopping spread spectrum (FHSS) technology, while EMI jamming can be countered with pulse-code modulation (PCM) or other digital modulation techniques.

Advantages offered by NGS-based RNA sequencing such as it provides a sensitive, and accurate assay of gene expressions which is increasingly the method of choice for scientists researching on the transcriptome. Moreover, RNA sequencing based on NGS captures both known and novel features. Also, it can generate both qualitative and quantitative data, saving the research time. The market is anticipated to be driven by significant factors, including an increase in cancer incidence, government research grants, and molecular biology technical developments. Moreover, contrarily, large-scale whole-genome sequencing (WGS), one of the most preferred methods in agriculture, forensics, and biofuels, is now affordable and manageable for a typical researcher by next-generation sequencing (NGS). It enables researchers to sequence thousands of genomes in a single year or to study the whole human genome in a single sequencing session.
Technological advancements in next-generation Sequencing (NGS) by top players are another factor increasing the growth of the global NGS-based RNA sequencing market. Illumina introduced its iSeq 100 System, a semiconductor sequencing technology. Sequencing by synthesis (SBS) chemistry is combined with a semiconductor chip in semiconductor sequencing technology.

To Know More: https://www.globalinsightservices.com/reports/ngs-based-rna-sequencing-market/?utm_id=1017

Research Objectives

• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Sample: https://www.globalinsightservices.com/request-sample/GIS10519/?utm_id=1017

Global NGS-based RNA Sequencing Market Segmental Overview

The report analyses the global NGS-based RNA Sequencing Market based on product & service, technology, application, and region.

Global NGS-based RNA Sequencing Market by Product & Services

The global NGS-based RNA sequencing market based on products & services is grouped into sample preparation, platforms & consumables, services, and data analysis. In 2021, the platforms and consumables segment held the greatest market share. This expansion is due to the ongoing technological advancements in the biotech industry. The rapidly expanding availability of innovative and affordable RNA sequencing systems, including library preparation, accelerates the segment growth. In addition, the services segment is predicted to expand at a high CAGR over the projection period due to the increasing use of services like RNA isolation, library preparation, sequencing, and data analysis as part of the full sample-to-insight solutions.
Global NGS-based RNA Sequencing Market by Technology Based on technology, the global NGS-based RNA sequencing market is grouped into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, and single-molecule real-time sequencing. The sequencing by synthesis (SBS) segment holds most of the market share. Sequencing by synthesis (SBS) is one of the widely used technology. Moreover, SBS provides robust performance and data quality; it provides unbiased coverage across the genome. Also SBS chemistry produces extremely precise sequencing using a single base extension and competitive nucleotide addition. Many top players, such as Illumina Inc. use the sequencing by synthesis (SBS) technique in their NGS systems, making it more affordable.

Global NGS-based RNA Sequencing Market by Application The global NGS-based RNA sequencing market is segmented on application into De novo, epigenetics, and small RNA. De novo sequencing is the process of sequencing a novel genome in the absence of an alignment table reference sequence. De novo assembly of RNA-seq data enables the study of the transcriptome, whether data are collected from a single organism or from a mixed sample, as in meta-transcriptomics investigations. NGS-based RNA sequencing in De Novo also helps clarify similar or repetitive regions for accurate de novo assembly. De novo also provides accurate data for the genome mapping of novel organisms.

Request Customization: https://www.globalinsightservices.com/request-customization/GIS10519/?utm_id=1017

Major Players in the Global Catamaran Market

The key players in the NGS-based RNA Sequencing Market are Agilent Technologies, Inc. , BGI Group, Eurofins Scientific SE, Genewiz, Inc. , F. Hoffman- La Roche AG, Thermo Fisher Scientific , Zymo Research Corporation, Psomagen, Inc. , Hamilton Company , Qiagen N.V. among others.

Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS10519/?utm_id=1017

Research Scope

• Scope - Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing - Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics - Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework - Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape - Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles - Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
• Market Size in 2021 - US$ 2.8 Billion
• Market Size in 2031 - US$ 21.3 Billion
• CAGR - 22.5%
• Historic Period - 2015-2022
• Forecast Period - 2024-2033
• Base Year - 2024

Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS10519/?utm_id=1017

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
•Unmatched data quality and after sales service

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release NGS-Based RNA-Sequencing Market Recent Developments Study Analysis By 2033 here

News-ID: 3348288 • Views:

More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing at 17.5% CAGR | Overall Study Report
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Overall Study Report
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAGR | Key Players: EasyMile, Navya, Aurrigo
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | Key Players: Apollo Tyres, Nokian Tyres, Hankook Tire
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may